Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Burt

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Hepatology (Baltimore, Md.)|October 1, 1995
Intrahepatic mast cells in chronic liver diseasesD J Farrell, J E Hines, A F Walls, et al.
Journal of Clinical Pathology|August 1, 1992
Glutathione S-transferases in neonatal liver diseaseJ Mathew, A R Cattan, A G Hall, et al.
The Journal of Pathology|September 1, 1989
Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studiesK J Hillan, A D Burt, W D George, et al.
Gut|June 14, 2005
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosisE Albano, E Mottaran, M Vidali, et al.
Gut|February 14, 2008
Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistanceJ L Newton, D E J Jones, E Henderson, et al.
Gut|April 6, 1999
Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver diseaseJ Grove, A K Daly, A D Burt, et al.
The American Journal of Gastroenterology|July 1, 1989
Risk factors and prognosis in primary biliary cirrhosisB M Goudie, A D Burt, G J Macfarlane, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis CB C Smith, J Gorve, M A Guzail, et al.
Clinical Endocrinology|January 1, 1987
Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytomaJ M Connell, R Corder, J Asbury, et al.
Journal of Hepatology|April 30, 2013
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy modelS M Robinson, J Mann, A Vasilaki, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|October 1, 1995
Intrahepatic mast cells in chronic liver diseasesD J Farrell, J E Hines, A F Walls, et al.
Journal of Clinical Pathology|August 1, 1992
Glutathione S-transferases in neonatal liver diseaseJ Mathew, A R Cattan, A G Hall, et al.
The Journal of Pathology|September 1, 1989
Intrasplenic hepatocyte transplantation in rats with experimental liver injury: morphological and morphometric studiesK J Hillan, A D Burt, W D George, et al.
Gut|June 14, 2005
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosisE Albano, E Mottaran, M Vidali, et al.
Gut|February 14, 2008
Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistanceJ L Newton, D E J Jones, E Henderson, et al.
Gut|April 6, 1999
Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver diseaseJ Grove, A K Daly, A D Burt, et al.
The American Journal of Gastroenterology|July 1, 1989
Risk factors and prognosis in primary biliary cirrhosisB M Goudie, A D Burt, G J Macfarlane, et al.
Hepatology (Baltimore, Md.)|June 10, 1998
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis CB C Smith, J Gorve, M A Guzail, et al.
Clinical Endocrinology|January 1, 1987
Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytomaJ M Connell, R Corder, J Asbury, et al.
Journal of Hepatology|April 30, 2013
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy modelS M Robinson, J Mann, A Vasilaki, et al.
Pageof 12